The Afflo Vest is the first truly portable, battery-operated High Frequency Chest Wall Oscillation (HFCWO) vest on the market, and is approved for Medicare and private health insurance reimbursement. The recent Cooper Study demonstrated lung function improvement including increased FEVI test results in 100% of the patients in this study.
The Afflo Vest weighs only 10 pounds depending on size and does not require air hoses or bulky generators, making it ideal for patients who travel or who need freedom of mobility.
The International Biophysics Corporation Afflo vest is intended for promoting airway clearance and improvement of bronchial drainage by enhancing mobilization of bronchial secretions where external manipulation of the thorax is the physician’s choice of treatment.
Are You Treating Patients with the Following?
Do You Have Patients with the Following?
Late Effects of Poliomyelitis
Other Deficiencies of Circulating Enzymes
Anterior Horn Cell Disease
Disorders of the Diaphragm
Recurrent Respiratory Infections
Mucus Plugging and Atelectasis
Hyper-Production of Secretions
Abnormally Think, Stick Secretions
Respiratory Muscle Weakness
Increased Risk for Aspiration
Physicians should consider the Afflo Vest for patients seeking a more mobile and convenient alternative to other HFCWO vest options. Afflo Vest is facilitating compliance as demonstrated in the Cooper Study, from patients due to its ease of use. Afflo Vest is demonstrating high patient compliance due to its ease of use.
For more information about treating patients with Bronchiectasis, call Sharon A. Furr at 941-623-2810 or email email@example.com.